Lactate dehydrogenase (LDH) is a predictor of clinical outcome in hepatocellular carcinoma (HCC) patients. However, its predictive role in the clinical outcomes of sorafenib treatment has been poorly documented. The correlation between LDH levels and clinical outcomes in HCC patients treated with sorafenib and included in the nationwide Italian database ITA.LI.CA was investigated here.

Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database / Sacco, R; Mismas, V; Granito, A; Musettini, G; Masi, G; Caparello, C; Vivaldi, C; Felder, M; Bresci, G; Fornaro, L.. - In: THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. - ISSN 0393-6155. - 30:1(2015), pp. e65-72-0. [10.5301/jbm.5000117]

Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database

2015

Abstract

Lactate dehydrogenase (LDH) is a predictor of clinical outcome in hepatocellular carcinoma (HCC) patients. However, its predictive role in the clinical outcomes of sorafenib treatment has been poorly documented. The correlation between LDH levels and clinical outcomes in HCC patients treated with sorafenib and included in the nationwide Italian database ITA.LI.CA was investigated here.
2015
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database / Sacco, R; Mismas, V; Granito, A; Musettini, G; Masi, G; Caparello, C; Vivaldi, C; Felder, M; Bresci, G; Fornaro, L.. - In: THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. - ISSN 0393-6155. - 30:1(2015), pp. e65-72-0. [10.5301/jbm.5000117]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/612536
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact